| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.05 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.24 | 0.05 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.29 | 0.06 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.06 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.06 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.06 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.098 | 0.06 |